MLS101
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for MLS101, covering 2024-10-09 to 2026-02-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study Assessing Brain Activity, Safety, Tolerability, and Pharmacokinetics Following Multiple Doses of MLS101 (Psilocybin) in Healthy Volunteers [Phase 1]